Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases and Medical Microbiology
Volume 16, Issue 4, Pages 230-232
http://dx.doi.org/10.1155/2005/971971
Original Article

Risk Factors for New-Onset Diabetes Mellitus in Patients Receiving Protease Inhibitor Therapy

Christine A Hughes,1 Richard P Cashin,2 Dean T Eurich,3 and Stan Houston4

1Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, and the Capital Health Region, Edmonton, Alberta, Canada
2Saskatoon Health Region, Saskatoon, Saskatchewan, Canada
3Institute of Health Economics and the Department of Public Health Sciences, University of Alberta, Canada
4Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada

Received 6 October 2004; Accepted 5 May 2005

Copyright © 2005 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Christine A Hughes, Richard P Cashin, Dean T Eurich, and Stan Houston, “Risk Factors for New-Onset Diabetes Mellitus in Patients Receiving Protease Inhibitor Therapy,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 16, no. 4, pp. 230-232, 2005. https://doi.org/10.1155/2005/971971.